EnteroMedics (ETRM) PT Trimmed at Canaccord Genuity, Still Sees Nearly 300% Upside
Tweet Send to a Friend
Canaccord Genuity analyst William Plovanic trimmed his price target on EnteroMedics (NASDAQ: ETRM) to $4.00 (from $5.00) but reiterated a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
